NewsBenzinga엔카르타, 5가지 자가면역 질환 적응증에서 세포 치료제의 안전성 프로파일 발표 엔카르타, 5가지 자가면역 질환 적응증에서 세포 치료제의 안전성 프로파일 발표 Benzinga 2026.11.11 15:44 (GMT+0) Open on Benzinga Other news Backpack Exchange Designated by CFTC as a Contract Market, Now Holding Both Trading and Clearing Qualifications All the questions Nvidia should answer on Tuesday — but probably won’t NYSE Parent ICE to Custody Abra's Institutional Crypto Loan Collateral Dear Klarna Stock Fans, Mark Your Calendars for November 17 Dear Starbucks Stock Fans, Mark Your Calendars for November 17 Freedom Holding Corp. Reports 81% Increase in Quarterly Revenue to $910.1 Million
Backpack Exchange Designated by CFTC as a Contract Market, Now Holding Both Trading and Clearing Qualifications